4//SEC Filing
Dalal Anupam 4
Accession 0001209191-22-051390
CIK 0001422142other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 7:20 PM ET
Size
6.2 KB
Accession
0001209191-22-051390
Insider Transaction Report
Form 4
Dalal Anupam
Director
Transactions
- Award
Common Stock
2022-09-26$12.50/sh+320,000$4,000,000→ 1,849,402 total(indirect: See footnote)
Holdings
- 1,130
Common Stock
Footnotes (1)
- [F1]Consists of (i) 1,572,698 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 276,704 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001602474
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 7:20 PM ET
- Size
- 6.2 KB